This is a Sponsored Post written by me on behalf of CryoCell International. All opinions are 100% mine.
Now that stem-cell therapy has been given the go-ahead in the U.S., there’s some really cool news that has recently come out. According to an April 2010 ‘Stem Cells and Development’ article, stem cell cultures derived from menstrual blood can provide therapy to stroke patients.
Stroke is the third-leading cause of death in the United States, according to the Centers for Disease Control.
This development is great news, because deriving stem cells from menstrual blood, as opposed to from bone marrow or umbilical cords, is easier to procure. When cultured, these cells have been shown to be save when injected in patients with multiple sclerosis.
This is some amazing news and could lead to further developments in stem cell research and therapy.
Cryo-Cell is collaborating with researchers world-wide on pre-clinical studies of Célle for potential future therapies that may possibly treat disorders such as diabetes; breast cancer and wound-healing, to name a few.
In published scientific research Célle stem cells have demonstrated potential to transform into many other cell types for future regenerative therapies.
Célle is being offered at a $100 discount on the $499 retail price with a special limited time offer for collection, processing, testing and 1st year storage at $399. Use code CLSTR for the discount.
Any therapy that can help prevent and aid what my friends and relatives have suffered in past years can only be positive. This is some great information!